{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T12:32:22Z","timestamp":1784118742677,"version":"3.55.0"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ymgmr.2024.101106","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T01:38:28Z","timestamp":1718329108000},"page":"101106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Histologic and ultrastructural study of intracranial Gaucheroma causing deafness in a patient with Gaucher disease type 3: Effects of substrate reduction therapy"],"prefix":"10.1016","volume":"40","author":[{"given":"Shoji","family":"Yano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"McGowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikako","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2024.101106_bb0005","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.anl.2017.05.013","article-title":"A case of improved hearing with cochlear implantation in Gaucher disease type 1","volume":"45","author":"Endo","year":"2018","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.ymgmr.2024.101106_bb0010","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1017\/S0022215113002521","article-title":"Middle-ear involvement in type 1 Gaucher\u2019s disease-a unique case","volume":"127","author":"Khan","year":"2013","journal-title":"J. Laryngol. Otol."},{"key":"10.1016\/j.ymgmr.2024.101106_bb0015","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1055\/s-2001-16611","article-title":"Audiometric abnormalities in children with Gaucher disease type 3","volume":"32","author":"DE","year":"2001","journal-title":"Neuropediatrics"},{"issue":"supplement_1","key":"10.1016\/j.ymgmr.2024.101106_bb0020","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1182\/blood-2019-128143","article-title":"Multidisciplinary study based on clinical, electrophysiological and psychological evaluations combined with advanced neuroimaging in Gaucher disease patients","volume":"134","author":"Giona","year":"2019","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.ymgmr.2024.101106_bb0025","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.038596","article-title":"mTOR hyperactivity mediates lysosomal dysfunction in Gaucher\u2019s disease iPSC-neuronal cell","volume":"12","author":"Brown","year":"2019","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ymgmr.2024.101106_bb0030","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1023\/B:BOLI.0000005619.14180.5c","article-title":"A model of neuronopathic Gaucher disease","volume":"26","author":"Campbell","year":"2003","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2024.101106_bb0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ymgme.2015.09.002","article-title":"Recommendations for the use of eliglustat in the treatment of adults with Gaucher disease type 1 in the United States","volume":"117","author":"Balwani","year":"2016","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgmr.2024.101106_bb0040","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao0935","article-title":"Delivery of therapeutics to the inner ear: the challenge of the blood-labyrinth barrier","volume":"11","author":"Nyberg","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgmr.2024.101106_bb0045","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1124\/pharmrev.120.000025","article-title":"ABCB1 and ABCG2 regulation at the blood-brain barrier: potential new targets to improve brain drug delivery","volume":"75","author":"Schulz","year":"2023","journal-title":"Pharmacol. Rev."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426924000594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426924000594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T19:35:12Z","timestamp":1723923312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426924000594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":9,"alternative-id":["S2214426924000594"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2024.101106","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histologic and ultrastructural study of intracranial Gaucheroma causing deafness in a patient with Gaucher disease type 3: Effects of substrate reduction therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2024.101106","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101106"}}